Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Akram Al-IbraheemDepartment of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.ORCID 0000-0002-0978-4716
Ahmad Saad AbdlkadirDepartment of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.ORCID 0000-0002-2009-5110
Nabil HasasnaDepartment of Cell Therapy & Applied Genomics, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.
Hasan AlalawiDepartment of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.
Ali MohamedkhairDepartment of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.
Salem Al-YazjeenDepartment of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.ORCID 0009-0000-4227-8658
Shahed ObeidatDepartment of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.
Obayda RabeiDepartment of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.
Dua'a Al-JarrahDepartment of Pathology, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.ORCID 0000-0002-4173-0996
Omar ShahinDepartment of Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.
Kamal Al-RabiDepartment of Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.ORCID 0009-0007-7492-6374
Mohammad MakosehDepartment of Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.ORCID 0000-0002-5103-0694
Nidal AlmasriDepartment of Pathology, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.ORCID 0000-0001-6009-7906
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.